Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nerd Hemp, yes not much about them, but then this says it all: " After choosing to delay the planned 2020 launch of the brand nationwide, the management team further refined and developed their AI Retail machine distribution relationships in preparation to initiate the delayed launch in the fourth quarter of 2022 and is now emerging from stealth mode"
TOMDF up 3.23% so far today
I firmly believe that , with all the research done by small Pharma in the last 3 years that there is likely a cure for the flu and a few other things already out there but the sector has died and hype and money are gone.
One Pharma I know has already gone thru Phase 3 with a preventative/treatment for Covid but still need to do another Phase 3 to satisfy FDA yet their product is available over the counter to 22% of the world population excluding North America and Europe
it ain't easy,
"Q4 is where many of the catalyst and milestones will take place for Todos."
Hope so and the AGM is the 28th of Sept .
BTW:
Who is the guy in the middle in that Football video about Todos,,,,see Link below
and I wonder if the TODOS shareprice would bounce if GMan01, (Gerald) announced a delay in it til 2024 or until the shareprice went up on its own merit
Who is the guy in the middle in that Football video about Todos,,,,
and I wonder if the TODOS shareprice would bounce if GMan01, (Gerald) announced a delay in it til 2024 or until the shareprice went up on its own merit
Some good advertizing for Todos Tollovid,,,,pardon my ignorance but who was the guy in the middle
RE Todos....but to answer when I refer to "split the shares with Gerald, the GMAN001....", I'm not talking about GMan111. from the TOMDF forum
Isn't flu seasonal ?
Covid can kill 3x as flu.
Does it mutate as often as Covid,
Covid creates 2 new variants a month?
You can get COVID-19 more than once. Many times, in fact.
Influenza doesn't leave people with symptoms like Long Covid (post-acute sequelae)
Tollovid by Todos is key
I'm jealous...hope you get it (Tollovid)soon and let us know your thoughts , if you don't mind Yay Todos
Let's hope as summer fades away and the summer doldrums with it we'll see an increase in volume.
I don't have Level 2 on this but it would seem there is little resistance?
Monday the shares went down again,13%, that's 3 days in a row that we've closed lower than the open.
The company is keeping us well informed on the day to day news.
The only news I want to hear is that they drop plans to reverse split the shares.
Has the company said what the payoff will be to those who join in on the Crowd funding?
It's unbelievable that in this day , with all the tools we have that we can show others the way to the truth yet they will blame the media, the government, the shorters , the Longs, Big Pharma ....yet not do a thing when the answer is right before them...handed to them on a silver platter if only they could see it for themselves.
Now I've gone and blown another post
Thankyou Mark, couldn't have said it better., but I wonder if Gerald is finally knuckling under pressure from the BOD and doing the wrong thing...I think the Longs here are trying to wear me down as well as use up my free posts LOL....ouch Rennie , okay ,duly noted
I have an idea, what about business as usual , prove the product, raise money let the shareprice rise on merit.
Then when everything is rosy and we're all rich , if the co. still want to uplist then do a share buyback to lower the o/s then let it rise again by attrition.
Would that work?
"Although at least 26 randomized clinical trials of long-COVID therapies are under way (see ‘Trials take off’), many are too small or lack the necessary control groups to give clear results. "
https://www.nature.com/articles/d41586-022-02140-w
Wow now that is a nice chronicle
That's quite a brilliant future for TOMDF.
"Why would anybody invest in a stock that was killed? If I felt that way, I would look to other stocks to invest in!"
Exactly what is happening now to TOMDF because of the upcoming split. Why is it so important to get uplisted to the NasDaq when we are still only a 2 cent stock....shouldn't we, couldn't we get there on merit?
What's the big attraction?
Nitric Oxide will be the next Penicillin, the new safe antimicrobial solution to Antibiotic resistance and there are only a few companies working on it
Generated Nitric Oxide
"Interpretation
Use of NONS ( Nitric Oxide Nasal Spray) in patients recently infected with SARS-CoV-2 accelerates nasal virus clearance.
A randomized, double-blind, multicentre, parallel group, placebo-controlled phase III clinical trial evaluated the ability of nitric oxide (NO) to rapidly eradicate nasal SARS-CoV-2 RNA. "
Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal
PRNE_Glenmark_Logo
NEWS PROVIDED BY
Glenmark Pharmaceuticals Ltd.
13 Jul, 2022, 16:43 IST
https://www.prnewswire.com/in/news-releases/glenmark-pharmaceuticals-and-sanotize-announce-peer-reviewed-publication-of-its-phase-3-clinical-trials-on-sanotize-s-novel-nitric-oxide-nasal-spray-for-covid-19-in-lancet-journal-882697493.html
Good point G ..buying a penny stock is not really investing , there are posts further back where we have discussed this , the problem for most who are in love with a stock is they hold it when it tanks and become bagholders (Longs).
I'm beginning to see your point tho, G and it is getting harder to hold this as the R/S looms and the shareprice tanks
Plant Products as Inhibitors of Coronavirus 3CL Protease
“Results: From the literature search, we have enlisted medicinal plants reported to inhibit coronavirus 3CL protease. Some of the plants like Isatis tinctoria L. (syn. Isatis indigotica Fort.), Torreya nucifera (L.) Siebold and Zucc., Psoralea corylifolia L., and Rheum palmatum L. have exhibited strong anti-3CLpro activity. We have also discussed about the phytochemicals with encouraging antiviral activity, such as, bavachinin, psoralidin, betulinic acid, curcumin and hinokinin, isolated from traditional medicinal plants.”
https://www.frontiersin.org/articles/10.3389/fphar.2021.583387/full?fbclid=IwAR1ahVBXubrDHm1gocKcWJZHhOg2LySXhD5x4hG9wruhHy3DBxx0UFBscQ8
Traditional Chinese Medicine (T.C.M.)
"Interestingly, of the new anticancer drugs developed between 1940 and 2002, approximately 54% were derived from natural products [31]. Another study has determined that of all current pharmaceutical products, about 73%, include ingredients derived from natural products [32]. The therapeutic activity of many traditional medicines are conferred by natural ingredients produced within the plant; consequently, the efficiency of TCM preparations can vary widely and are determined by the genotype, environmental, and growing conditions encountered by each source plant
4.28. Lithospermum erythrorhizon
The dried root of Lithospermum erythrorhizon is indigenous to northeast China and has potent biological activities, including anti-inflammatory, antibacterial, antiangiogenic, and antitumour qualities [261]. Shikonin, a naphthoquinone, is extracted from the root of Lithospermum erythrorhizon and stimulates the activity of caspases, poly-(ADP-ribosyl) polymerase (PARP) and reactive oxygen species (ROS), triggering programmed cell death in cancer cell lines [262]. These characteristics prompted investigation of shikonin as a novel scar remediation therapy. These studies found that shikonin inhibits cell proliferation and collagen production in hypertrophic scar-derived human skin fibroblasts [263]. Arnebin-1, a related naphthoquinone extracted from Lithospermum erythrorhizon, has been reported to synergise with VEGF, resulting in significantly improved wound healing in a rat diabetic model [264]."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778887/
Nitric oxide is a colorless, free radical gas composed of nitrogen and oxygen that has demonstrated antimicrobial effects. It is theorized to have anti-viral properties as well and thus may help prevent and/or treat severe forms of SARS-CoV-2 infection.
ORGANIZATIONS
Brand new study from Singapore on N.O. Delivery etc.
Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications
https://www.mdpi.com/1420-3049/27/3/674/htm
“In the meantime, Canada's SaNOtize Research & Development Corp's Nitric Oxide Nasal Spray (NONS) is set to be manufactured and marketed in India by Glenmark Pharmaceuticals Ltd once it receives DCGI approval.”
https://fit.thequint.com/coronavirus/vaccine-treatment/antiviral-nasal-spray-for-covid-19-experts-speak#read-more
Brand new study from Singapore on N.O. Delivery etc.
Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications
https://www.mdpi.com/1420-3049/27/3/674/htm
And also products derived from Traditional Chinese Medicine ( TCM)
Thanks H/B appreciate it
Follow the money, is that a worthy topic, how to make money in stocks?
LOL there is a group offering an app that would allow you to make trades based on the politicians trading patterns LOL....follow the money, I guess
Two days ago the NYT posted an investigation into politicians trading stocks
They found that 81 Democrats & 101 Republicans filed up to 3,700 trades and $100M in possible volume
Many had 100% winners, with some perfectly timed
Here’s examples of just how good they were
Two days ago the NYT posted an investigation into politicians trading stocks
— Chris Josephs (@Chrisjjosephs) September 15, 2022
They found that 81 Democrats & 101 Republicans filed up to 3,700 trades and $100M in possible volume
Many had 100% winners, with some perfectly timed
Here’s examples of just how good they were
Oh I see vcf...yes good point. I misread that oops
VCF5502 a 10 for 1 split would take this to .19 and that's not enough to attract Inst Buyers
My impression is that Gerald is likely feeling pressure from the BOD, since they are mentioned in the wording on the Ballot. Gerald does not have the final say.
As far as timing one could argue that the lower starting point the better, in fact think how many o/s shares they could be rid of with a 200 : 1 split for the NasDaq and look how that changes if the sp is at 1 cent....that would mean 400 for 1 share. with the o/s at 1,400,000,000 and a split of 400;1, that's quite a reduction.
The lack of upward movement in the last few weeks should be telling them a few things . Buyers are weary because of the threat to split and NR's full of promises no longer move the shareprice....expectations are already built into the stock.
R/s do fail , if you search far enough you will find it verified and just the intent to spit does damage.
You have lots of shares as do I. Wouldn't you be buying more at this dip if you weren't being a bit more careful now? I sure would be, but I'm not.
Good idea to hedge your bet , you can be sure that Institutional Investors hedge as well
Yes but when I saw it listed as one of the key votes on the Proxy it is obvious that it has moved up in priority. And as GMAN said in his post "Why invest here when you know that a reverse split is going to happen?"
Thanks for asking G, so it is going to happen...
To answer your query, I don't "invest" in Penny stocks but I do have a few in my account in a buy an Hold pattern.
I learned a long time ago not to go Long and fall in love with a stock.
And even tho I normally don't talk about what I hold, I do have TOMDF, and have added at least once but now that the intentions to split have resurfaced I am taking a hard look at whether or not to get out.
If it wasn't for the split I would certainly have bought more on this dip, but like many others I'm not.
Good summary you nailed it, incidentally there was an alternate board here for 3CL Pharma but it was recently shut down for posting
Reverse Split History:
GPR only announced a R/S shareprice went from .16 to .125,
Dec only announced a R/S shareprice went from .125 to .105,
Vaxil only announced a R/S shareprice went from .05 to .03,
Clas-v did a split last year the pre split price was .025 and a 20 to 1 R/S went ahead......1 year later the shareprice is back down to .025 again since the split and the company is now under a CTO because they have no money, it's done, finished
By Todos announcing their intent..... they have killed this stock
Share Consolidation to come:
Just the mention of getting the R/S "re-aurthorised " so that the BOD can run things is enough to send this stock spiralling, just look at the last 2 weeks since the Proxy went out.
Usually penny stocks mask their reasons for the split behind an uplisting attempt or making the stock more attractive to institutional inventors.
In order for TOMDF to achieve this, either they would need to do a 200 to 1 r/s for the NasDaq or at minimum a 25 to 1 to attract institutional investors.
Either way there are often other reasons for the split. With 1,200,000.000 outstanding shares it is likely the co would love to bring that down so that they can start building it up again.
Outside Investors also like to see at least 50 cents after the split so that they can set benchmark loans, tranches, and have room to hedge their investment/loan in other ways.
The Pharma sector was hot but has been dead for almost 2 years. TOMDF or actually 3CL Pharma would have to do a huge public relations promo for their CrowdFunding scheme then follow that up with a string of excellent new press releases to keep the interest going to sustain the TOMDF shareprice.
On top of all that when a company artificially raises it's shereprice it has further to fall and opens itself to ruthless investors like shorters and hedgefunds betting, on the odds, that the consolidation will fail. Often even the Lenders will prevail once the shreprice falls and money is tight and milestones don't get met
It's a tragedy and history shows that share consolidations in penny and micropenny stocks will fail but some others will make money either way
Just the mention of getting the R/S "re-aurthorised " so that the BOD can run things is enough to send this stock spiralling, just look at the last 2 weeks since the Proxy went out.
Usually penny stocks mask their reasons for the split behind an uplisting attempt or making the stock more attractive to institutional inventors.
In order for TOMDF to achieve this, either they would need to do a 200 to 1 r/s for the NasDaq or at minimum a 25 to 1 to attract institutional investors.
Either way there are often other reasons for the split. With 1,200,000,000 outstanding shares it is likely the co would love to bring that down so that they can start building it up again.
Outside Investors also like to see at least 50 cents after the split so that they can set benchmark loans, tranches, and have room to hedge their investment/loan in other ways.
The Pharma sector was hot but has been dead for almost 2 years. TOMDF or actually 3CL Pharma would have to do a huge public relations promo for their CrowdFunding scheme then follow that up with a string of excellent new press releases to keep the interest going to sustain the TOMDF shareprice.
On top of all that when a company artificially raises it's shereprice it has further to fall and opens itself to ruthless investors like shorters and hedgefunds betting, on the odds, that the consolidation will fail. Often even the Lenders will prevail once the shareprice falls and money is tight and milestones don't get met
It's a tragedy and history shows that share consolidations in penny and micropenny stocks will fail but some others will make money either way
"As a consequence, NLC Pharma has assigned ownership of all relevant intellectual property to majority-owned joint venture 3CL Pharma Ltd. The assignment includes the patent applications for dual mechanism (3CL protease inhibitor and CCR5 antagonist) Phase 2 therapeutic drug candidate Tollovir™, commercial-stage 3CL protease inhibitor immune support supplement Tollovid™, and 3CL protease biomarker test TolloTest™ for SARS-CoV-2 infectivity monitoring and PASC/Long COVID viral persistence assessment (“The IP”)."
Todos Medical Partner NLC Pharma Assigns IP for Tollovir(TM), Tollovid(TM), and TolloTest(TM) into JV 3CL Pharma
https://stockhouse.com/news/press-releases/2022/09/12/todos-medical-partner-nlc-pharma-assigns-ip-for-tollovir-tm-tollovid-tm-and
TODOS the mother company of 3CL Pharma is planning a reverse split and has created a Newco to handle Tollovid and Tollovir and this private Newco....3CL Pharma (not sure if the name will stick) is going to raise million$ in a crowd funding deal then possibly spin off from Todos and NCL (private) as a Public traded company
To purchase the product Tollovid please visit Amazon or www.MyTollovid.com. For more information, please visit https://www.todosmedical.com/.
"Todos formed the Israeli-based majority-owned joint venture 3CL Pharma, Ltd with NLC Pharma in March of 2022 to consolidate all of the intellectual property surrounding 3CL protease–based diagnostic testing and development of 3CL protease botanical and pharmaceutical inhibitors that target a fundamental reproductive mechanism of coronaviruses.
3CL Pharma, through Todos’ brand, has commercialized the 3CL protease inhibitor immune support dietary supplement Tollovid™ in the United States, is developing the dual mechanism 3CL protease inhibitor and anti-cytokine therapeutic drug candidate Tollovir™, while also developing the 3CL protease diagnostic TolloTest™."
https://investor.todosmedical.com/news-events/press-releases/detail/231/todos-medical-announces-nfl-hall-of-famer-michael-irvin-as
When a sector is hot , good news generates instant positive shareprice reaction and that usually goes with all similar stocks with products or services that meet that expectation.
The shareprice goes up. Once that sector cools down that instant reaction on good news doesn't necessarily pop like before. Reasons being that the sector is no longer front page news and also some good news is already built into the current shareprice....volume/interest disappears.
2 years ago remember what was hot in Pharma? Companies supplying test kits, companies working on Vaccines, alternate treatments, clinics....the list goes on. That has all cooled down now.
next time you are in a stock that announces intentions to R/S....run for your life
“It’s not your customer’s job to remember you. It is your obligation and responsibility to make sure they don’t have the chance to forget you.”
Thanks, for posting, I feel so much better now
Penny and micropenny stocks like TODOS should never be considered "an investment" get in, get out ,get in , get out....make money on them, don't fall in love with them,
Refuse to be a long term Bagholder